why choose us

First received: February 27, 2024

Clinical Trial: A Study Of TL-925 For The Treatment of AC

Study Status: Completed

Recruit Status: RECRUITING

Condition: Allergic Conjunctivitis

Study Type: INTERVENTIONAL


Official Title: A Single Center, Randomized, Double-masked, Vehicle-controlled Phase 2b Study Evaluating the Safety and Efficacy of TL-925 Ophthalmic Emulsion 0.1% Compared to Vehicle for the Treatment of Allergic Co

Brief Summary: In this prospective, Phase 2, randomized, double-masked, vehicle controlled study, approximately 70 eligible subjects will be randomized 1:1 to receive either TL-925 or placebo as topical ophthalmic eye drops administered bilaterally.The study comprises of a screening and treatment period using the conjunctival allergen challenge model to evaluate TL-925 for the treatment of allergic conjunctivitis.

Read more